ChromaDex Corporation (NASDAQ:CDXC) Q3 2023 Earnings Conference Call November 8, 2023 4:30 PM ET

Company Participants

Kendall Knysch - Director, Media Relations

Rob Fried - CEO

Brianna Gerber - CFO

Conference Call Participants

Ram Selvaraju - H.C. Wainwright

Mitch Pinheiro - Sturdivant

JP Mark - Farmhouse Equity Research

Matt Dhane - Tieton Capital Management

Operator

Hello and thank you for standing by. My name is Regina and I'll be your conference operator today. At this time, I'd like to welcome everyone to the ChromaDex Corporation Third Quarter 2023 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speaker’s remarks there’ll be a question and answer session. [Operator Instructions].

I would now like to turn the conference over to Kendall Knysch, Head of Public Relations and partnerships. Please go ahead.

Kendall Knysch

Thank you. Good afternoon and welcome to ChromaDex Corporation's third quarter 2023 results investor call. With us today are ChromaDex's Chief Executive Officer, Rob Fried, Chief Financial Officer, Brianna Gerber, and Senior Vice President of Scientific and Regulatory Affairs, Dr. Andrew Shao, who will join the call for Q&A.

Today's conference call may include forward-looking statements, including statements related to ChromaDex's research and development and clinical trial plans and the timing and results of such trials, the timing of future regulatory filings, the expansion of the sale of Tru Niagen in new markets, business development opportunities, future financial results, cash needs, operating performance, investor interest, and business prospects and opportunities, as well as anticipated results of operations.

Forward-looking statements represent only the company's estimates on the date of this conference call and are not intended to give any assurance as to actual future results. Because forward-looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties.

Many factors could cause ChromaDex’s actual activities or results to differ materially from the activities and results anticipated in forward-looking statements. These risk factors include those contained in ChromaDex’s quarterly reports on Form 10-Q most recently filed with the SEC, including results of operations, financial condition, cash flows, adverse global market and economic conditions on our business.

Please note that the company assumes no obligation to update any forward-looking statements after the date of this conference call to conform with the forward-looking statements, actual results, or to changes in its expectations.

In addition, certain of the financial information presented in this call references non-GAAP financial measures. The company's earnings presentation and earnings press release, which were issued this afternoon and are available on the company's website, presents reconciliations to the appropriate GAAP measures.